Healthcare provider profile · identity verified

Matthew A Kresca, MD

Internal Medicine · CHAMPAIGN, IL · NPI 1770078743

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	415	122
Amlodipine Besylate	Amlodipine Besylate	317	99
Rosuvastatin Calcium	Rosuvastatin Calcium	267	79
Lisinopril	Lisinopril	238	71
Levothyroxine Sodium	Levothyroxine Sodium	233	57
Gabapentin	Gabapentin	211	57
Omeprazole	Omeprazole	173	52
Metoprolol Succinate	Metoprolol Succinate	138	43
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	135	39
Pantoprazole Sodium	Pantoprazole Sodium	126	41
Metformin Hcl Er	Metformin Hcl	124	34
Hydrochlorothiazide	Hydrochlorothiazide	118	39
Trazodone Hcl	Trazodone Hcl	118	35
Losartan Potassium	Losartan Potassium	117	43
Albuterol Sulfate Hfa	Albuterol Sulfate	103	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	28
Metoprolol Tartrate	Metoprolol Tartrate	102	24
Alendronate Sodium	Alendronate Sodium	101	29
Duloxetine Hcl	Duloxetine Hcl	94	27
Ozempic	Semaglutide	91	16
Furosemide	Furosemide	90	28
Carvedilol	Carvedilol	84	28
Metformin Hcl	Metformin Hcl	83	28
Spironolactone	Spironolactone	76	27
Jardiance	Empagliflozin	73	20
Tamsulosin Hcl	Tamsulosin Hcl	73	23
Eliquis	Apixaban	70	19
Meloxicam	Meloxicam	70	31
Simvastatin	Simvastatin	70	23
Ezetimibe	Ezetimibe	64	19
Sertraline Hcl	Sertraline Hcl	63	21
Tizanidine Hcl	Tizanidine Hcl	58	20
Clopidogrel	Clopidogrel Bisulfate	57	18
Fluticasone Propionate	Fluticasone Propionate	56	24
Tramadol Hcl	Tramadol Hcl	56	12
Allopurinol	Allopurinol	54	16
Potassium Chloride	Potassium Chloride	54	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	18
Pravastatin Sodium	Pravastatin Sodium	51	21
Glipizide Er	Glipizide	50	13
Prednisone	Prednisone	49	31
Methylprednisolone	Methylprednisolone	47	43
Famotidine	Famotidine	44	15
Citalopram Hbr	Citalopram Hydrobromide	43	15
Donepezil Hcl	Donepezil Hcl	42	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	19
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	suppressed
Lorazepam	Lorazepam	37	12
Montelukast Sodium	Montelukast Sodium	37	13
Chlorthalidone	Chlorthalidone	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	28
Bupropion Xl	Bupropion Hcl	34	suppressed
Buspirone Hcl	Buspirone Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	14
Azithromycin	Azithromycin	33	31
Torsemide	Torsemide	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Finasteride	Finasteride	31	12
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Aripiprazole	Aripiprazole	29	suppressed
Alprazolam	Alprazolam	28	15
Memantine Hcl	Memantine Hcl	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Rybelsus	Semaglutide	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	27	24
Olanzapine	Olanzapine	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	11
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Mounjaro	Tirzepatide	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Digoxin	Digoxin	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	15
Myrbetriq	Mirabegron	22	suppressed
Sulindac	Sulindac	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	20	13
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Cephalexin	Cephalexin	18	15
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	15
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Fluconazole	Fluconazole	14	11
Glipizide	Glipizide	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Soliqua 100-33	Insulin Glargine/Lixisenatide	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error